HAX is a venture capital program focused on accelerating hardware startups through its comprehensive support and resources. Founded in 2012 and headquartered in Newark, New Jersey, HAX operates in two key locations, San Francisco and Shenzhen, providing founders with an environment conducive to rapid prototyping and iterative development. The program emphasizes the importance of launching both B2C and B2B hardware startups, guiding them through critical phases such as business development, fundraising, and market entry. HAX accepts teams that demonstrate strong potential for scaling their ventures and solving significant technological challenges. Through a structured curriculum, entrepreneurs refine their product-market fit and business strategies while benefiting from a robust network of mentors and industry connections. HAX maintains an ongoing relationship with participating startups to support their growth beyond the initial program, ensuring they have the necessary resources and partnerships to succeed in the competitive marketplace.
Vision IV develops, produces diamond integrated anvil to evaluate, change and synthesize the properties of susbstances under high pressure.
InnSight Technology
Seed Round in 2025
InnSight Technology is a biotechnology company focused on enhancing diagnostics and evaluation of eye diseases. The company develops innovative ophthalmic devices, including a novel hand-held biosensor designed for the detection of anterior ophthalmic injuries. Additionally, InnSight Technology works on advanced nanotechnology-based medical devices aimed at addressing specific clinical needs in ophthalmology. By providing these tools, the company seeks to improve ocular care for clinicians and their patients.
Sharper Sense
Seed Round in 2025
Sharper Sense is a company focused on wearable neurotechnology designed to enhance sensory acuity, including vision, hearing, and touch. The firm has developed a neuromodulation patch that employs comfortable, noninvasive electrical stimulation to improve sensory processing. This technology has both clinical and commercial applications, particularly in treating sensory processing disorders and sensory loss. By enhancing performance and safety, Sharper Sense aims to provide users with a clearer and more accurate perception of their surroundings.
Macheon
Seed Round in 2024
Macheon AI is a robotics company specializing in the manufacture of surgical robots for head and neck procedures. These robots incorporate real-time, AI-driven decision support, aiming to enhance surgical precision, safety, and efficiency.
OLI
Seed Round in 2024
Medical Devices, Kidney Disease, Wearables, Medtech, Hardtech
Bloomlife
Series B in 2024
Bloomlife is a women's health company focused on addressing critical challenges in maternal health through an innovative remote care platform. By integrating connected devices with cloud-based data analytics, Bloomlife enhances access to care and empowers expectant mothers while providing clinicians with essential information to better screen and manage pregnancy complications. The company's prenatal wearable technology is designed to assess fetal health, enabling the identification of potential complications that could lead to serious outcomes such as brain damage or stillbirth. This approach marks a significant departure from traditional methods of managing high-risk pregnancies, which often involve frequent in-person appointments and lengthy referral processes. Bloomlife aims to be a leader in remote maternal care, facilitating timely interventions and support for women, regardless of geographic barriers.
Medical Devices Corner
Pre Seed Round in 2024
Medical Devices Corner is a company focused on developing innovative medical devices aimed at enhancing cancer diagnosis and treatment. Their primary offering is a novel robotic system designed to facilitate minimally invasive surgeries. By advancing device technology, the company supports healthcare professionals in performing procedures that include biopsies and ablations with reduced invasiveness. Through its commitment to improving surgical techniques, Medical Devices Corner plays a crucial role in the health industry, striving to enhance patient outcomes and streamline medical processes.
ZiO Health
Convertible Note in 2024
ZiO Health is a biotechnology company that focuses on transforming laboratory testing through its proprietary pocket-sized technology, which allows for point-of-care diagnostics. By combining advanced biosensor technology with machine learning algorithms, ZiO Health provides real-time testing results tailored to each patient's unique profile. This innovative approach enables users to measure, test, and detect the molecular composition of various substances, facilitating personalized health insights. The company's devices aim to optimize health management and enhance patient outcomes, allowing individuals to conduct quality home diagnostics and take proactive steps in preventing illness.
Zhenshi Medical
Convertible Note in 2024
Zhenshi Medical is a medical device company that specializes in lung puncture medical robots for diagnosing and treating lung cancer.
DeepSpin
Convertible Note in 2024
DeepSpin GmbH, founded in 2019 and based in Berlin, Germany, specializes in developing artificial intelligence-powered magnetic resonance imaging (MRI) equipment. The company’s innovative technology aims to provide MRI imaging systems that are significantly smaller, lighter, and more cost-effective than traditional models. By leveraging generative topological design and deep learning techniques, DeepSpin's MRI machines enhance accessibility to medical imaging, making it available to a wider range of patients globally. This approach seeks to improve healthcare standards in various medical fields previously lacking adequate imaging solutions.
Kegg
Series A in 2024
Kegg is a fertility tracking device that combines the functions of monitoring vaginal fluid and facilitating pelvic floor exercises. Founded in 2017 and based in San Francisco, California, Kegg utilizes advanced sensing technology to detect changes in cervical fluid, thereby enabling women to identify their fertile window and ovulation up to seven days in advance. This innovative approach provides essential data that enhances the diagnosis, monitoring, and treatment of women's reproductive health, significantly increasing the chances of natural conception. By offering an intuitive and effective solution, Kegg empowers women with the information they need to make informed decisions regarding their fertility.
FeetMe
Series B in 2024
FeetMe is a digital health company specializing in advanced technology for gait and activity assessments in both clinical and real-world settings. The company develops innovative wearable products, particularly smart insoles equipped with pressure sensors and motion analysis algorithms. These products enable real-time monitoring of patients' mobility and posture, facilitating comprehensive evaluations of movement disorders and mobility constraints. By providing relevant digital biomarkers, FeetMe aims to support clinical research and enhance patient care, allowing healthcare professionals to track disease progression, improve functional outcomes, and optimize treatment strategies.
Lief Therapeutics
Seed Round in 2024
Lief Therapeutics is a medical device company focused on improving at-home care for individuals suffering from post-traumatic stress disorder, depression, and anxiety. The company has developed a discreet biosensing patch that measures heart rate and breathing patterns with medical accuracy. This wearable device, known as Lief, helps users manage their stress responses through biofeedback exercises, allowing them to monitor their emotions and behaviors in real-time. Additionally, the device provides clinicians with insights into patient progress, enabling in-session training and tracking of psychological assessments. Lief Therapeutics also offers the Lief Health Score application, which records thoughts, emotions, and sensations, facilitating the tracking of daily progress and personalized practice exercises. Founded in 2014 and based in San Francisco, California, the company sells its products online.
Strados Labs
Convertible Note in 2024
Strados Labs, LLC is a medical technology company based in Philadelphia, Pennsylvania, that focuses on innovating respiratory health management through advanced biosensors and artificial intelligence. Founded in 2016, Strados Labs develops a wearable device that provides real-time insights into respiratory metrics such as breathing speed, sounds, and patterns. This device is equipped with a continuous breathing sensor that enables remote monitoring of patients with respiratory conditions like asthma and chronic obstructive pulmonary disease. By connecting the device to a mobile application, patients and healthcare providers can access critical respiratory data, facilitating informed decision-making and improved management of respiratory health.
XN Health
Convertible Note in 2024
XN Health is a medical device company based in Texas, founded in 2021. The company specializes in developing healthcare devices aimed at improving the process of mechanical ventilation. Its innovative technology focuses on phrenic nerve stimulation, which induces diaphragm contractions during ventilation. This approach helps protect against diaphragm dysfunction in patients who are mechanically ventilated, ultimately enabling them to wean off the ventilator more quickly and safely.
3DK Tech
Seed Round in 2023
3DK Tech, located at HAX, specializes in advanced metal 3D printing technology aimed at enhancing manufacturing processes for various industries, including aerospace, medical, and automotive. The company has developed a proprietary method that improves the selective laser melting (SLM) process, allowing for the production of complex parts with exceptional precision and efficiency. This innovation offers significant advantages, delivering parts that are 200 times more durable, produced 10 times faster, and at a cost 10 times more effective than traditional manufacturing methods. By focusing on aviation maintenance, repair, and operations (MRO), 3DK Tech provides businesses with the ability to create high-quality components that meet rigorous industry standards.
Lura Health
Seed Round in 2023
Lura Health has developed a groundbreaking non-invasive health monitoring platform that utilizes saliva as a diagnostic fluid, aiming to enhance clinical outcomes in chronic disease management. Founded in 2017 and based in Cambridge, Massachusetts, the company targets various chronic disease markets, including heart disease, chronic kidney disease, diabetes, and tooth decay. Its innovative sensors are integrated into patient-friendly orthodontic devices such as removable retainers and fixed braces. These sensors continuously measure analytes in saliva and automatically transmit data to a smartphone application, allowing users to track key diagnostic metrics related to their oral health. By enabling individuals to monitor their health in real-time, Lura Health seeks to improve personal health management and empower users to take charge of their well-being.
OLI
Seed Round in 2023
Medical Devices, Kidney Disease, Wearables, Medtech, Hardtech
Feel Therapeutics
Convertible Note in 2023
Feel Therapeutics is a digital precision medicine company focused on improving mental health through objective data and passive monitoring. It develops physiological and digital biomarkers alongside therapeutics that aid in the diagnosis, management, and care of mental health conditions. The company's platform includes proprietary medical-grade wearables, such as a wristband equipped with five embedded sensors, which collect biometric data. This data is analyzed using advanced computational methods to create digital biomarkers. By integrating these technologies, Feel Therapeutics aims to provide users with evidence-based insights that enhance their mental well-being and foster the development of lasting positive emotional habits.
Artyc
Series A in 2023
Artyc specializes in providing sustainable cold shipping solutions for the biotech, pharmaceutical, and medical sectors. The company manufactures refrigerant-free, reusable, active cooling containers designed to decarbonize the cold chain, thereby fostering a more sustainable logistics industry. By utilizing these innovative containers, businesses can benefit from reduced shipping costs and enhanced temperature monitoring throughout their logistics operations, ensuring the safe and efficient transport of temperature-sensitive goods.
Optimize Health
Series B in 2023
Optimize Health is a digital healthcare provider specializing in remote patient monitoring (RPM) solutions. The company offers a user-friendly platform that incorporates both equipment and software designed to streamline the implementation of RPM programs. Its software aids healthcare providers in complying with Medicare billing requirements for RPM services while ensuring a positive experience for both patients and providers. The platform automatically tracks medication doses and sends reminders to users, leveraging Bluetooth technology to sync with smartphones and tablets. This approach empowers patients to manage their health effectively and enables physicians to achieve profitability from RPM services starting in the first month.
Medical Devices Corner
Convertible Note in 2023
Medical Devices Corner is a company focused on developing innovative medical devices aimed at enhancing cancer diagnosis and treatment. Their primary offering is a novel robotic system designed to facilitate minimally invasive surgeries. By advancing device technology, the company supports healthcare professionals in performing procedures that include biopsies and ablations with reduced invasiveness. Through its commitment to improving surgical techniques, Medical Devices Corner plays a crucial role in the health industry, striving to enhance patient outcomes and streamline medical processes.
DIA
Grant in 2023
Dia has invented an electrochemical sensor that can measure a wide variety of chemical biomarkers non-invasively in saliva or sweat. The data is sent via Bluetooth to an app on the user’s smartphone and analyzed in real-time. From the app, it can be securely sent to a third party. To date, we have measured hormones, electrolytes, neurotransmitters and metabolites. At DIA, we let the biology dictate which analyte we put on which platform – our wearable arm sleeve for sweat or our table-top device for saliva – because some biomarkers, such as cortisol fluctuate throughout the day and need to be monitored through a wearable sensor, while others, such as creatinine are more suitable to a daily saliva test.
Japet
Convertible Note in 2023
Japet Medical Devices is a French biomedical company focused on developing innovative robotic equipment aimed at enhancing treatment quality. The company specializes in wearable robotic exoskeletons that integrate medical and robotic technologies to assist with both occupational and daily health needs. These exoskeletons are designed to restore balance and facilitate free movement, offering pain relief through orthotic support. Japet's commitment to creating user-friendly solutions reflects its belief in the transformative potential of these technologies to improve the quality of life for many individuals.
Lief Therapeutics
Convertible Note in 2022
Lief Therapeutics is a medical device company focused on improving at-home care for individuals suffering from post-traumatic stress disorder, depression, and anxiety. The company has developed a discreet biosensing patch that measures heart rate and breathing patterns with medical accuracy. This wearable device, known as Lief, helps users manage their stress responses through biofeedback exercises, allowing them to monitor their emotions and behaviors in real-time. Additionally, the device provides clinicians with insights into patient progress, enabling in-session training and tracking of psychological assessments. Lief Therapeutics also offers the Lief Health Score application, which records thoughts, emotions, and sensations, facilitating the tracking of daily progress and personalized practice exercises. Founded in 2014 and based in San Francisco, California, the company sells its products online.
Kinexcs
Convertible Note in 2022
Kinexcs is an AI-driven health platform and wearables company focused on enhancing mobility and improving quality of life for individuals with musculoskeletal conditions. It addresses issues of incomplete recovery and patient compliance through its innovative digital therapy solutions, which are both cost-effective and convenient. The company has developed KIMIA, the world's first continuous knee health monitor, combined with an AI-based digital therapist that facilitates access to therapy. Kinexcs collaborates with key opinion leaders and major public hospitals in Singapore on various clinical projects, while also offering its products through orthopedic surgeons and significant implant manufacturers. The integration of continuous monitoring and real-time exercise guidance supports patients in managing their conditions effectively.
FluidAI
Seed Round in 2022
FluidAI Medical is a company dedicated to enhancing patient care through innovative technology in post-operative recovery. It has developed a smart catheter system that employs artificial intelligence to monitor patients' health data within the body. This proactive approach enables the early detection of postoperative complications, allowing healthcare providers to access critical health information promptly. By leveraging data-driven insights, FluidAI aims to improve recovery outcomes and transform the standards of post-operative care.
Artyc
Seed Round in 2022
Artyc specializes in providing sustainable cold shipping solutions for the biotech, pharmaceutical, and medical sectors. The company manufactures refrigerant-free, reusable, active cooling containers designed to decarbonize the cold chain, thereby fostering a more sustainable logistics industry. By utilizing these innovative containers, businesses can benefit from reduced shipping costs and enhanced temperature monitoring throughout their logistics operations, ensuring the safe and efficient transport of temperature-sensitive goods.
Artyc
Convertible Note in 2022
Artyc specializes in providing sustainable cold shipping solutions for the biotech, pharmaceutical, and medical sectors. The company manufactures refrigerant-free, reusable, active cooling containers designed to decarbonize the cold chain, thereby fostering a more sustainable logistics industry. By utilizing these innovative containers, businesses can benefit from reduced shipping costs and enhanced temperature monitoring throughout their logistics operations, ensuring the safe and efficient transport of temperature-sensitive goods.
Portable Diagnostic Systems
Seed Round in 2022
Portable Diagnostic Systems is focused on developing a microfluidics-based drug testing platform tailored for law enforcement applications. Founded in August 2019, the company aims to enhance roadside drug screening by providing accurate results from a small saliva sample. This innovative approach employs salivary diagnostics and antibody engineering, allowing for quick and easy collection during traffic stops. The platform is designed to minimize false positives and meet the specific needs of police departments, thereby improving the reliability of drug testing in impaired driving cases.
Zennea Technologies
Convertible Note in 2022
Zennea Technologies is a medical device company based in Surrey, Canada, specializing in the development of therapeutic wearables aimed at reducing snoring and improving overall health through enhanced sleep quality. The company's flagship product, ZENS, is a comfortable and discreet wearable designed to address chronic snoring and mild obstructive sleep apnea at its source. Zennea conducts clinical trials to validate the effectiveness of its technology, which not only targets snoring but also tracks sleep quality, assisting users in making informed decisions to enhance their sleep health.
FeetMe
Convertible Note in 2022
FeetMe is a digital health company specializing in advanced technology for gait and activity assessments in both clinical and real-world settings. The company develops innovative wearable products, particularly smart insoles equipped with pressure sensors and motion analysis algorithms. These products enable real-time monitoring of patients' mobility and posture, facilitating comprehensive evaluations of movement disorders and mobility constraints. By providing relevant digital biomarkers, FeetMe aims to support clinical research and enhance patient care, allowing healthcare professionals to track disease progression, improve functional outcomes, and optimize treatment strategies.
Harae Dx
Convertible Note in 2022
Harae Dx Corp. is a medical diagnostics company specializing in cancer detection. The company has created an automated, portable system that facilitates early cancer diagnosis by identifying cancer biomarkers directly, eliminating the need to send samples to third-party laboratories. This innovative approach reduces the risk of human error in processing and enhances the speed of results, allowing healthcare professionals to detect and treat cancer more effectively and affordably. Harae Dx's compact and cost-efficient solution aims to improve patient outcomes through timely and accurate diagnostics.
Leadoptik
Angel Round in 2022
Leadoptik is a deep-tech company focused on developing advanced miniature imaging technology designed for minimally invasive medical procedures. Its platform enhances surgical capabilities by providing high-resolution imaging and 3D navigation in real time, allowing surgeons to visualize small anatomical structures with greater clarity than existing imaging systems. This innovative approach facilitates the early detection of cancer and improves the overall effectiveness of surgical interventions, ultimately contributing to better patient outcomes.
Hydrostasis
Convertible Note in 2021
Hydrostasis is a company based in San Diego, California, that specializes in developing hydration monitoring systems tailored for athletes. Its technology includes wearable sensors that assess individual hydration needs based on body composition, providing personalized and clinical-grade accuracy. The system offers real-time notifications to alert athletes before dehydration affects their performance. In addition to serving athletes, Hydrostasis collaborates with device manufacturers for both consumer and clinical applications, enhancing hydration monitoring capabilities across various platforms. By leveraging scientific methodologies and cloud-based data storage, Hydrostasis aims to empower athletes to optimize their hydration levels, ultimately supporting their physical and mental performance.
Criam
Seed Round in 2021
Criam is a biotechnology company based in Braga, Portugal, founded in 2015. It specializes in the research and development of a medical device designed for blood type analysis and the detection of infectious diseases. The company's flagship product offers rapid and accurate testing for various conditions, including HIV, Brucella, tick fever, syphilis, mononucleosis, and meningitis. This portable device operates independently of electricity or laboratory infrastructure, making it accessible for use in diverse environments. Additionally, Criam's technology is scalable, allowing a single reader to perform multiple tests using specific cartridges and advanced computer vision algorithms. By optimizing blood testing services, Criam aims to provide timely health information and improve clinical decision-making.
XXICO
Seed Round in 2021
XXICO is a platform consisting of devices and software that enable remote health monitoring.
Harae Dx
Seed Round in 2021
Harae Dx Corp. is a medical diagnostics company specializing in cancer detection. The company has created an automated, portable system that facilitates early cancer diagnosis by identifying cancer biomarkers directly, eliminating the need to send samples to third-party laboratories. This innovative approach reduces the risk of human error in processing and enhances the speed of results, allowing healthcare professionals to detect and treat cancer more effectively and affordably. Harae Dx's compact and cost-efficient solution aims to improve patient outcomes through timely and accurate diagnostics.
DeepSpin
Convertible Note in 2021
DeepSpin GmbH, founded in 2019 and based in Berlin, Germany, specializes in developing artificial intelligence-powered magnetic resonance imaging (MRI) equipment. The company’s innovative technology aims to provide MRI imaging systems that are significantly smaller, lighter, and more cost-effective than traditional models. By leveraging generative topological design and deep learning techniques, DeepSpin's MRI machines enhance accessibility to medical imaging, making it available to a wider range of patients globally. This approach seeks to improve healthcare standards in various medical fields previously lacking adequate imaging solutions.
Medical Devices Corner
Seed Round in 2021
Medical Devices Corner is a company focused on developing innovative medical devices aimed at enhancing cancer diagnosis and treatment. Their primary offering is a novel robotic system designed to facilitate minimally invasive surgeries. By advancing device technology, the company supports healthcare professionals in performing procedures that include biopsies and ablations with reduced invasiveness. Through its commitment to improving surgical techniques, Medical Devices Corner plays a crucial role in the health industry, striving to enhance patient outcomes and streamline medical processes.
Leadoptik
Seed Round in 2020
Leadoptik is a deep-tech company focused on developing advanced miniature imaging technology designed for minimally invasive medical procedures. Its platform enhances surgical capabilities by providing high-resolution imaging and 3D navigation in real time, allowing surgeons to visualize small anatomical structures with greater clarity than existing imaging systems. This innovative approach facilitates the early detection of cancer and improves the overall effectiveness of surgical interventions, ultimately contributing to better patient outcomes.
Kegg
Convertible Note in 2020
Kegg is a fertility tracking device that combines the functions of monitoring vaginal fluid and facilitating pelvic floor exercises. Founded in 2017 and based in San Francisco, California, Kegg utilizes advanced sensing technology to detect changes in cervical fluid, thereby enabling women to identify their fertile window and ovulation up to seven days in advance. This innovative approach provides essential data that enhances the diagnosis, monitoring, and treatment of women's reproductive health, significantly increasing the chances of natural conception. By offering an intuitive and effective solution, Kegg empowers women with the information they need to make informed decisions regarding their fertility.
Elephant Robotics
Convertible Note in 2020
Elephant Robotics, based in the United States, specializes in developing cooperative robots. These robots feature integrated robot arms, voice, and vision systems, making them suitable for tasks such as pick and place, packaging, and testing. The company's products aim to facilitate automation upgrades, ensuring safe work environments, low production costs, and reduced deployment time and risk. Elephant Robotics serves a wide range of industries, including medical, education, agriculture, scientific research, and transportation.
Strados Labs
Convertible Note in 2020
Strados Labs, LLC is a medical technology company based in Philadelphia, Pennsylvania, that focuses on innovating respiratory health management through advanced biosensors and artificial intelligence. Founded in 2016, Strados Labs develops a wearable device that provides real-time insights into respiratory metrics such as breathing speed, sounds, and patterns. This device is equipped with a continuous breathing sensor that enables remote monitoring of patients with respiratory conditions like asthma and chronic obstructive pulmonary disease. By connecting the device to a mobile application, patients and healthcare providers can access critical respiratory data, facilitating informed decision-making and improved management of respiratory health.
Sepsitron
Pre Seed Round in 2020
Sepsitron specializes in medical diagnostic technology that enables the rapid detection of blood infections caused by various pathogens, including viral, bacterial, parasitic, and fungal agents. The company's innovative approach utilizes unique biomarkers, microfluidics, and advanced electronics to provide a diagnostic device that is significantly faster and more cost-effective than traditional methods. Sepsitron's tests require no sample pre-processing and can analyze whole blood samples, allowing for the precise identification of multiple pathogens from a single test. This technology aims to enhance the speed and effectiveness of disease detection and treatment for healthcare professionals. Sepsitron has garnered support from prominent startup accelerators, positioning itself as a leader in point-of-care diagnostics.
DeepSpin
Seed Round in 2020
DeepSpin GmbH, founded in 2019 and based in Berlin, Germany, specializes in developing artificial intelligence-powered magnetic resonance imaging (MRI) equipment. The company’s innovative technology aims to provide MRI imaging systems that are significantly smaller, lighter, and more cost-effective than traditional models. By leveraging generative topological design and deep learning techniques, DeepSpin's MRI machines enhance accessibility to medical imaging, making it available to a wider range of patients globally. This approach seeks to improve healthcare standards in various medical fields previously lacking adequate imaging solutions.
Lura Health
Convertible Note in 2020
Lura Health has developed a groundbreaking non-invasive health monitoring platform that utilizes saliva as a diagnostic fluid, aiming to enhance clinical outcomes in chronic disease management. Founded in 2017 and based in Cambridge, Massachusetts, the company targets various chronic disease markets, including heart disease, chronic kidney disease, diabetes, and tooth decay. Its innovative sensors are integrated into patient-friendly orthodontic devices such as removable retainers and fixed braces. These sensors continuously measure analytes in saliva and automatically transmit data to a smartphone application, allowing users to track key diagnostic metrics related to their oral health. By enabling individuals to monitor their health in real-time, Lura Health seeks to improve personal health management and empower users to take charge of their well-being.
nura
Series A in 2020
Nura Operations Pty Ltd. is an Australian company founded in 2016 and headquartered in Brunswick. The firm specializes in the development and manufacture of innovative headphones that personalize sound based on users' neural responses to music. Its flagship product, the nuraphone, employs advanced technology to automatically assess individual hearing profiles, adapting audio output to suit each listener's unique auditory characteristics. This personalization is achieved by measuring responses from the outer ear to the brain, ensuring that the headphones deliver an optimal listening experience. Additionally, the nuraphones feature a recognition capability that identifies users upon wearing them, enhancing the personalized experience further.
Zennea Technologies
Seed Round in 2020
Zennea Technologies is a medical device company based in Surrey, Canada, specializing in the development of therapeutic wearables aimed at reducing snoring and improving overall health through enhanced sleep quality. The company's flagship product, ZENS, is a comfortable and discreet wearable designed to address chronic snoring and mild obstructive sleep apnea at its source. Zennea conducts clinical trials to validate the effectiveness of its technology, which not only targets snoring but also tracks sleep quality, assisting users in making informed decisions to enhance their sleep health.
Babybe
Convertible Note in 2019
Babybe GmbH is a medical device company based in Stuttgart, Germany, that specializes in products designed for premature babies and their mothers. Founded in 2013 by Raphael P. M. Lang and Camilo Anabalon, the company developed the Babybe System, a unique bionic mattress that simulates the mother's heartbeat, breathing, and voice, providing multisensory stimulation to preterm infants during their time in incubators. This innovative device facilitates a real-time connection between mother and child, enhancing the baby's recovery process and neurodevelopmental outcomes. The Babybe System is the only Class 1 medical device on the market aimed at improving the bonding experience during artificial incubation, which can lead to reduced healthcare costs and increased efficiency in neonatal intensive care units (NICUs). As of November 2020, Babybe operates as a subsidiary of Natus Medical Incorporated.
Kegg
Convertible Note in 2019
Kegg is a fertility tracking device that combines the functions of monitoring vaginal fluid and facilitating pelvic floor exercises. Founded in 2017 and based in San Francisco, California, Kegg utilizes advanced sensing technology to detect changes in cervical fluid, thereby enabling women to identify their fertile window and ovulation up to seven days in advance. This innovative approach provides essential data that enhances the diagnosis, monitoring, and treatment of women's reproductive health, significantly increasing the chances of natural conception. By offering an intuitive and effective solution, Kegg empowers women with the information they need to make informed decisions regarding their fertility.
Sepsitron
Pre Seed Round in 2019
Sepsitron specializes in medical diagnostic technology that enables the rapid detection of blood infections caused by various pathogens, including viral, bacterial, parasitic, and fungal agents. The company's innovative approach utilizes unique biomarkers, microfluidics, and advanced electronics to provide a diagnostic device that is significantly faster and more cost-effective than traditional methods. Sepsitron's tests require no sample pre-processing and can analyze whole blood samples, allowing for the precise identification of multiple pathogens from a single test. This technology aims to enhance the speed and effectiveness of disease detection and treatment for healthcare professionals. Sepsitron has garnered support from prominent startup accelerators, positioning itself as a leader in point-of-care diagnostics.
Japet
Convertible Note in 2019
Japet Medical Devices is a French biomedical company focused on developing innovative robotic equipment aimed at enhancing treatment quality. The company specializes in wearable robotic exoskeletons that integrate medical and robotic technologies to assist with both occupational and daily health needs. These exoskeletons are designed to restore balance and facilitate free movement, offering pain relief through orthotic support. Japet's commitment to creating user-friendly solutions reflects its belief in the transformative potential of these technologies to improve the quality of life for many individuals.
Feel Therapeutics
Seed Round in 2019
Feel Therapeutics is a digital precision medicine company focused on improving mental health through objective data and passive monitoring. It develops physiological and digital biomarkers alongside therapeutics that aid in the diagnosis, management, and care of mental health conditions. The company's platform includes proprietary medical-grade wearables, such as a wristband equipped with five embedded sensors, which collect biometric data. This data is analyzed using advanced computational methods to create digital biomarkers. By integrating these technologies, Feel Therapeutics aims to provide users with evidence-based insights that enhance their mental well-being and foster the development of lasting positive emotional habits.
Seein Health
Venture Round in 2019
Seein Health is a developer of pro-pregnancy products focused on enhancing fertility and supporting maternal health. The company offers a range of products, including thermometers, menstrual test strips, and advanced physiological parameter monitoring equipment. These products aim to ensure the health and safety of pregnant mothers by providing essential tools for monitoring fertility and pregnancy status. Additionally, Seein Health provides overseas services related to test-tube baby procedures and frozen eggs, further contributing to reproductive health solutions.
Zennea Technologies
Convertible Note in 2019
Zennea Technologies is a medical device company based in Surrey, Canada, specializing in the development of therapeutic wearables aimed at reducing snoring and improving overall health through enhanced sleep quality. The company's flagship product, ZENS, is a comfortable and discreet wearable designed to address chronic snoring and mild obstructive sleep apnea at its source. Zennea conducts clinical trials to validate the effectiveness of its technology, which not only targets snoring but also tracks sleep quality, assisting users in making informed decisions to enhance their sleep health.
Kinexcs
Seed Round in 2019
Kinexcs is an AI-driven health platform and wearables company focused on enhancing mobility and improving quality of life for individuals with musculoskeletal conditions. It addresses issues of incomplete recovery and patient compliance through its innovative digital therapy solutions, which are both cost-effective and convenient. The company has developed KIMIA, the world's first continuous knee health monitor, combined with an AI-based digital therapist that facilitates access to therapy. Kinexcs collaborates with key opinion leaders and major public hospitals in Singapore on various clinical projects, while also offering its products through orthopedic surgeons and significant implant manufacturers. The integration of continuous monitoring and real-time exercise guidance supports patients in managing their conditions effectively.
ZiO Health
Seed Round in 2019
ZiO Health is a biotechnology company that focuses on transforming laboratory testing through its proprietary pocket-sized technology, which allows for point-of-care diagnostics. By combining advanced biosensor technology with machine learning algorithms, ZiO Health provides real-time testing results tailored to each patient's unique profile. This innovative approach enables users to measure, test, and detect the molecular composition of various substances, facilitating personalized health insights. The company's devices aim to optimize health management and enhance patient outcomes, allowing individuals to conduct quality home diagnostics and take proactive steps in preventing illness.
Bravrr
Pre Seed Round in 2019
Bravrr, LLC is a company based in Canon City, Colorado, specializing in the development of wearable diagnostic and therapeutic tools. Founded in 2019, Bravrr's flagship product, BruxRelief, is a smart biofeedback wearable designed to detect, treat, and eliminate bruxism disorder, which affects approximately one in three individuals, yet remains largely undiagnosed. The BruxRelief headband utilizes advanced sensors and artificial intelligence to monitor clenching and grinding behaviors in the temporalis muscle, allowing users to identify stress triggers associated with these actions. The device connects to a smartphone app that analyzes users' bruxism behavior and sleep patterns, providing an accessible solution in a market where existing diagnostic tools are often overly complex and expensive. By offering a simple, effective means to address bruxism, Bravrr aims to improve the quality of life for those suffering from this painful condition.
Strados Labs
Seed Round in 2019
Strados Labs, LLC is a medical technology company based in Philadelphia, Pennsylvania, that focuses on innovating respiratory health management through advanced biosensors and artificial intelligence. Founded in 2016, Strados Labs develops a wearable device that provides real-time insights into respiratory metrics such as breathing speed, sounds, and patterns. This device is equipped with a continuous breathing sensor that enables remote monitoring of patients with respiratory conditions like asthma and chronic obstructive pulmonary disease. By connecting the device to a mobile application, patients and healthcare providers can access critical respiratory data, facilitating informed decision-making and improved management of respiratory health.
Bold Diagnostics
Convertible Note in 2019
Bold Diagnostics is a medical device startup focused on developing an innovative diagnostic platform for blood pressure monitoring. The company has created a device that optimizes hypertension and pressure management by utilizing a novel parameter to derive noninvasive, cuffless blood pressure measurements. This pocket-sized device allows for ambulatory cardiovascular diagnostics, providing both patients and physicians with an accurate, comfortable, and convenient alternative for measuring and monitoring blood pressure. Through its technology, Bold Diagnostics aims to enhance the management of cardiovascular health.
Elephant Robotics
Seed Round in 2019
Elephant Robotics, based in the United States, specializes in developing cooperative robots. These robots feature integrated robot arms, voice, and vision systems, making them suitable for tasks such as pick and place, packaging, and testing. The company's products aim to facilitate automation upgrades, ensuring safe work environments, low production costs, and reduced deployment time and risk. Elephant Robotics serves a wide range of industries, including medical, education, agriculture, scientific research, and transportation.
Zennea Technologies
Convertible Note in 2019
Zennea Technologies is a medical device company based in Surrey, Canada, specializing in the development of therapeutic wearables aimed at reducing snoring and improving overall health through enhanced sleep quality. The company's flagship product, ZENS, is a comfortable and discreet wearable designed to address chronic snoring and mild obstructive sleep apnea at its source. Zennea conducts clinical trials to validate the effectiveness of its technology, which not only targets snoring but also tracks sleep quality, assisting users in making informed decisions to enhance their sleep health.
Lura Health
Seed Round in 2019
Lura Health has developed a groundbreaking non-invasive health monitoring platform that utilizes saliva as a diagnostic fluid, aiming to enhance clinical outcomes in chronic disease management. Founded in 2017 and based in Cambridge, Massachusetts, the company targets various chronic disease markets, including heart disease, chronic kidney disease, diabetes, and tooth decay. Its innovative sensors are integrated into patient-friendly orthodontic devices such as removable retainers and fixed braces. These sensors continuously measure analytes in saliva and automatically transmit data to a smartphone application, allowing users to track key diagnostic metrics related to their oral health. By enabling individuals to monitor their health in real-time, Lura Health seeks to improve personal health management and empower users to take charge of their well-being.
Babybe
Convertible Note in 2018
Babybe GmbH is a medical device company based in Stuttgart, Germany, that specializes in products designed for premature babies and their mothers. Founded in 2013 by Raphael P. M. Lang and Camilo Anabalon, the company developed the Babybe System, a unique bionic mattress that simulates the mother's heartbeat, breathing, and voice, providing multisensory stimulation to preterm infants during their time in incubators. This innovative device facilitates a real-time connection between mother and child, enhancing the baby's recovery process and neurodevelopmental outcomes. The Babybe System is the only Class 1 medical device on the market aimed at improving the bonding experience during artificial incubation, which can lead to reduced healthcare costs and increased efficiency in neonatal intensive care units (NICUs). As of November 2020, Babybe operates as a subsidiary of Natus Medical Incorporated.
nura
Series A in 2018
Nura Operations Pty Ltd. is an Australian company founded in 2016 and headquartered in Brunswick. The firm specializes in the development and manufacture of innovative headphones that personalize sound based on users' neural responses to music. Its flagship product, the nuraphone, employs advanced technology to automatically assess individual hearing profiles, adapting audio output to suit each listener's unique auditory characteristics. This personalization is achieved by measuring responses from the outer ear to the brain, ensuring that the headphones deliver an optimal listening experience. Additionally, the nuraphones feature a recognition capability that identifies users upon wearing them, enhancing the personalized experience further.
Kinexcs
Seed Round in 2018
Kinexcs is an AI-driven health platform and wearables company focused on enhancing mobility and improving quality of life for individuals with musculoskeletal conditions. It addresses issues of incomplete recovery and patient compliance through its innovative digital therapy solutions, which are both cost-effective and convenient. The company has developed KIMIA, the world's first continuous knee health monitor, combined with an AI-based digital therapist that facilitates access to therapy. Kinexcs collaborates with key opinion leaders and major public hospitals in Singapore on various clinical projects, while also offering its products through orthopedic surgeons and significant implant manufacturers. The integration of continuous monitoring and real-time exercise guidance supports patients in managing their conditions effectively.
Elephant Robotics
Seed Round in 2018
Elephant Robotics, based in the United States, specializes in developing cooperative robots. These robots feature integrated robot arms, voice, and vision systems, making them suitable for tasks such as pick and place, packaging, and testing. The company's products aim to facilitate automation upgrades, ensuring safe work environments, low production costs, and reduced deployment time and risk. Elephant Robotics serves a wide range of industries, including medical, education, agriculture, scientific research, and transportation.
Seein Health
Seed Round in 2018
Seein Health is a developer of pro-pregnancy products focused on enhancing fertility and supporting maternal health. The company offers a range of products, including thermometers, menstrual test strips, and advanced physiological parameter monitoring equipment. These products aim to ensure the health and safety of pregnant mothers by providing essential tools for monitoring fertility and pregnancy status. Additionally, Seein Health provides overseas services related to test-tube baby procedures and frozen eggs, further contributing to reproductive health solutions.
Sana Health
Seed Round in 2018
Sana Health, Inc. is a digital health company specializing in a bio-therapeutic device aimed at fostering relaxation to alleviate pain and tension. The company has developed a non-addictive mask and headphone system that employs audio-visual stimulation to enhance the balance between the brain's left and right hemispheres, facilitating a deep state of meditation. This innovative device uses coordinated pulses of light and sound to guide users into a restorative state, thereby improving mental well-being and addressing chronic pain and insomnia. In addition to the hardware, Sana Health offers a mobile application available on both the App Store and Google Play, allowing users to access its features conveniently. Founded in 2015 and headquartered in Lafayette, Colorado, with an additional office in Mill Valley, California, Sana Health is involved in pivotal studies concerning its technology's applications for conditions such as fibromyalgia and neuropathic pain, as well as trials focusing on anxiety and PTSD.
Babybe
Series A in 2018
Babybe GmbH is a medical device company based in Stuttgart, Germany, that specializes in products designed for premature babies and their mothers. Founded in 2013 by Raphael P. M. Lang and Camilo Anabalon, the company developed the Babybe System, a unique bionic mattress that simulates the mother's heartbeat, breathing, and voice, providing multisensory stimulation to preterm infants during their time in incubators. This innovative device facilitates a real-time connection between mother and child, enhancing the baby's recovery process and neurodevelopmental outcomes. The Babybe System is the only Class 1 medical device on the market aimed at improving the bonding experience during artificial incubation, which can lead to reduced healthcare costs and increased efficiency in neonatal intensive care units (NICUs). As of November 2020, Babybe operates as a subsidiary of Natus Medical Incorporated.
Kegg
Convertible Note in 2018
Kegg is a fertility tracking device that combines the functions of monitoring vaginal fluid and facilitating pelvic floor exercises. Founded in 2017 and based in San Francisco, California, Kegg utilizes advanced sensing technology to detect changes in cervical fluid, thereby enabling women to identify their fertile window and ovulation up to seven days in advance. This innovative approach provides essential data that enhances the diagnosis, monitoring, and treatment of women's reproductive health, significantly increasing the chances of natural conception. By offering an intuitive and effective solution, Kegg empowers women with the information they need to make informed decisions regarding their fertility.
ZiO Health
Seed Round in 2018
ZiO Health is a biotechnology company that focuses on transforming laboratory testing through its proprietary pocket-sized technology, which allows for point-of-care diagnostics. By combining advanced biosensor technology with machine learning algorithms, ZiO Health provides real-time testing results tailored to each patient's unique profile. This innovative approach enables users to measure, test, and detect the molecular composition of various substances, facilitating personalized health insights. The company's devices aim to optimize health management and enhance patient outcomes, allowing individuals to conduct quality home diagnostics and take proactive steps in preventing illness.
Bold Diagnostics
Seed Round in 2018
Bold Diagnostics is a medical device startup focused on developing an innovative diagnostic platform for blood pressure monitoring. The company has created a device that optimizes hypertension and pressure management by utilizing a novel parameter to derive noninvasive, cuffless blood pressure measurements. This pocket-sized device allows for ambulatory cardiovascular diagnostics, providing both patients and physicians with an accurate, comfortable, and convenient alternative for measuring and monitoring blood pressure. Through its technology, Bold Diagnostics aims to enhance the management of cardiovascular health.
Bitome
Convertible Note in 2018
Bitome is a Boston-based company specializing in connected medical devices, focusing on noninvasive hydration monitoring technology. Established two years ago, Bitome's first product is designed to monitor hydration status, with significant applications in fields such as dialysis, diabetes management, sports performance, and maternal/fetal health. One of its primary uses is in assessing volume status in patients with congestive heart failure (CHF), a critical but challenging biometric to measure that is closely linked to patient outcomes. By enhancing hydration monitoring, Bitome aims to revolutionize CHF management in a manner similar to how glucose monitoring transformed diabetes care.
Zennea Technologies
Pre Seed Round in 2018
Zennea Technologies is a medical device company based in Surrey, Canada, specializing in the development of therapeutic wearables aimed at reducing snoring and improving overall health through enhanced sleep quality. The company's flagship product, ZENS, is a comfortable and discreet wearable designed to address chronic snoring and mild obstructive sleep apnea at its source. Zennea conducts clinical trials to validate the effectiveness of its technology, which not only targets snoring but also tracks sleep quality, assisting users in making informed decisions to enhance their sleep health.
Criam
Convertible Note in 2018
Criam is a biotechnology company based in Braga, Portugal, founded in 2015. It specializes in the research and development of a medical device designed for blood type analysis and the detection of infectious diseases. The company's flagship product offers rapid and accurate testing for various conditions, including HIV, Brucella, tick fever, syphilis, mononucleosis, and meningitis. This portable device operates independently of electricity or laboratory infrastructure, making it accessible for use in diverse environments. Additionally, Criam's technology is scalable, allowing a single reader to perform multiple tests using specific cartridges and advanced computer vision algorithms. By optimizing blood testing services, Criam aims to provide timely health information and improve clinical decision-making.
Pillsy
Seed Round in 2017
Pillsy is an enterprise-grade platform for remote patient support and rapid development of connected medication experiences. It is a new smart pill bottle and app that uses behavioral science to support healthy habits around vitamins and medications. It also securely share the pill-taking information with loved ones and to help monitor people. Pillsy was founded in 2015 and is headquartered in Seattle, Washington.
Babybe
Convertible Note in 2017
Babybe GmbH is a medical device company based in Stuttgart, Germany, that specializes in products designed for premature babies and their mothers. Founded in 2013 by Raphael P. M. Lang and Camilo Anabalon, the company developed the Babybe System, a unique bionic mattress that simulates the mother's heartbeat, breathing, and voice, providing multisensory stimulation to preterm infants during their time in incubators. This innovative device facilitates a real-time connection between mother and child, enhancing the baby's recovery process and neurodevelopmental outcomes. The Babybe System is the only Class 1 medical device on the market aimed at improving the bonding experience during artificial incubation, which can lead to reduced healthcare costs and increased efficiency in neonatal intensive care units (NICUs). As of November 2020, Babybe operates as a subsidiary of Natus Medical Incorporated.
Kegg
Seed Round in 2017
Kegg is a fertility tracking device that combines the functions of monitoring vaginal fluid and facilitating pelvic floor exercises. Founded in 2017 and based in San Francisco, California, Kegg utilizes advanced sensing technology to detect changes in cervical fluid, thereby enabling women to identify their fertile window and ovulation up to seven days in advance. This innovative approach provides essential data that enhances the diagnosis, monitoring, and treatment of women's reproductive health, significantly increasing the chances of natural conception. By offering an intuitive and effective solution, Kegg empowers women with the information they need to make informed decisions regarding their fertility.
Fuller Vision
Seed Round in 2017
Fuller Vision develops innovative autofocusing glasses specifically designed for individuals with advanced presbyopia. By utilizing advanced technology, including artificial intelligence for eye tracking, miniaturized cameras, and sensors, the company creates dynamic lenses that replicate the natural focusing ability of younger eyes. This technology enables users to retain a full range of focusing power well into their 60s and beyond, improving their visual experience and quality of life.
AptaCam
Pre Seed Round in 2017
AptaCam is a biotechnology company based in Shenzhen, China, that specializes in the development of biosensors for the detection of human papillomavirus (HPV) and other infectious diseases. Founded in 2014, the company also creates software that enhances the functionality of its portable diagnostic devices by enabling data analysis and collection when connected to a computer. AptaCam aims to be a leading producer of high-quality aptamers, which are short, single-stranded molecules that can be tailored for high specificity to various targets. The company's innovative platform supports clinical diagnostics, drug discovery, and monitoring in medical, environmental, and food safety applications. Through its commitment to simplifying molecular recognition, AptaCam provides comprehensive aptamer solutions across diverse disciplines.
Kinexcs
Pre Seed Round in 2017
Kinexcs is an AI-driven health platform and wearables company focused on enhancing mobility and improving quality of life for individuals with musculoskeletal conditions. It addresses issues of incomplete recovery and patient compliance through its innovative digital therapy solutions, which are both cost-effective and convenient. The company has developed KIMIA, the world's first continuous knee health monitor, combined with an AI-based digital therapist that facilitates access to therapy. Kinexcs collaborates with key opinion leaders and major public hospitals in Singapore on various clinical projects, while also offering its products through orthopedic surgeons and significant implant manufacturers. The integration of continuous monitoring and real-time exercise guidance supports patients in managing their conditions effectively.
Japet
Seed Round in 2017
Japet Medical Devices is a French biomedical company focused on developing innovative robotic equipment aimed at enhancing treatment quality. The company specializes in wearable robotic exoskeletons that integrate medical and robotic technologies to assist with both occupational and daily health needs. These exoskeletons are designed to restore balance and facilitate free movement, offering pain relief through orthotic support. Japet's commitment to creating user-friendly solutions reflects its belief in the transformative potential of these technologies to improve the quality of life for many individuals.
ZiO Health
Convertible Note in 2017
ZiO Health is a biotechnology company that focuses on transforming laboratory testing through its proprietary pocket-sized technology, which allows for point-of-care diagnostics. By combining advanced biosensor technology with machine learning algorithms, ZiO Health provides real-time testing results tailored to each patient's unique profile. This innovative approach enables users to measure, test, and detect the molecular composition of various substances, facilitating personalized health insights. The company's devices aim to optimize health management and enhance patient outcomes, allowing individuals to conduct quality home diagnostics and take proactive steps in preventing illness.
nura
Seed Round in 2017
Nura Operations Pty Ltd. is an Australian company founded in 2016 and headquartered in Brunswick. The firm specializes in the development and manufacture of innovative headphones that personalize sound based on users' neural responses to music. Its flagship product, the nuraphone, employs advanced technology to automatically assess individual hearing profiles, adapting audio output to suit each listener's unique auditory characteristics. This personalization is achieved by measuring responses from the outer ear to the brain, ensuring that the headphones deliver an optimal listening experience. Additionally, the nuraphones feature a recognition capability that identifies users upon wearing them, enhancing the personalized experience further.
Sana Health
Convertible Note in 2017
Sana Health, Inc. is a digital health company specializing in a bio-therapeutic device aimed at fostering relaxation to alleviate pain and tension. The company has developed a non-addictive mask and headphone system that employs audio-visual stimulation to enhance the balance between the brain's left and right hemispheres, facilitating a deep state of meditation. This innovative device uses coordinated pulses of light and sound to guide users into a restorative state, thereby improving mental well-being and addressing chronic pain and insomnia. In addition to the hardware, Sana Health offers a mobile application available on both the App Store and Google Play, allowing users to access its features conveniently. Founded in 2015 and headquartered in Lafayette, Colorado, with an additional office in Mill Valley, California, Sana Health is involved in pivotal studies concerning its technology's applications for conditions such as fibromyalgia and neuropathic pain, as well as trials focusing on anxiety and PTSD.
ZiO Health
Seed Round in 2017
ZiO Health is a biotechnology company that focuses on transforming laboratory testing through its proprietary pocket-sized technology, which allows for point-of-care diagnostics. By combining advanced biosensor technology with machine learning algorithms, ZiO Health provides real-time testing results tailored to each patient's unique profile. This innovative approach enables users to measure, test, and detect the molecular composition of various substances, facilitating personalized health insights. The company's devices aim to optimize health management and enhance patient outcomes, allowing individuals to conduct quality home diagnostics and take proactive steps in preventing illness.
Fuller Vision
Convertible Note in 2017
Fuller Vision develops innovative autofocusing glasses specifically designed for individuals with advanced presbyopia. By utilizing advanced technology, including artificial intelligence for eye tracking, miniaturized cameras, and sensors, the company creates dynamic lenses that replicate the natural focusing ability of younger eyes. This technology enables users to retain a full range of focusing power well into their 60s and beyond, improving their visual experience and quality of life.
Elephant Robotics
Convertible Note in 2016
Elephant Robotics, based in the United States, specializes in developing cooperative robots. These robots feature integrated robot arms, voice, and vision systems, making them suitable for tasks such as pick and place, packaging, and testing. The company's products aim to facilitate automation upgrades, ensuring safe work environments, low production costs, and reduced deployment time and risk. Elephant Robotics serves a wide range of industries, including medical, education, agriculture, scientific research, and transportation.
Criam
Convertible Note in 2016
Criam is a biotechnology company based in Braga, Portugal, founded in 2015. It specializes in the research and development of a medical device designed for blood type analysis and the detection of infectious diseases. The company's flagship product offers rapid and accurate testing for various conditions, including HIV, Brucella, tick fever, syphilis, mononucleosis, and meningitis. This portable device operates independently of electricity or laboratory infrastructure, making it accessible for use in diverse environments. Additionally, Criam's technology is scalable, allowing a single reader to perform multiple tests using specific cartridges and advanced computer vision algorithms. By optimizing blood testing services, Criam aims to provide timely health information and improve clinical decision-making.
Japet
Convertible Note in 2016
Japet Medical Devices is a French biomedical company focused on developing innovative robotic equipment aimed at enhancing treatment quality. The company specializes in wearable robotic exoskeletons that integrate medical and robotic technologies to assist with both occupational and daily health needs. These exoskeletons are designed to restore balance and facilitate free movement, offering pain relief through orthotic support. Japet's commitment to creating user-friendly solutions reflects its belief in the transformative potential of these technologies to improve the quality of life for many individuals.
Bitome
Convertible Note in 2016
Bitome is a Boston-based company specializing in connected medical devices, focusing on noninvasive hydration monitoring technology. Established two years ago, Bitome's first product is designed to monitor hydration status, with significant applications in fields such as dialysis, diabetes management, sports performance, and maternal/fetal health. One of its primary uses is in assessing volume status in patients with congestive heart failure (CHF), a critical but challenging biometric to measure that is closely linked to patient outcomes. By enhancing hydration monitoring, Bitome aims to revolutionize CHF management in a manner similar to how glucose monitoring transformed diabetes care.
Criam
Seed Round in 2016
Criam is a biotechnology company based in Braga, Portugal, founded in 2015. It specializes in the research and development of a medical device designed for blood type analysis and the detection of infectious diseases. The company's flagship product offers rapid and accurate testing for various conditions, including HIV, Brucella, tick fever, syphilis, mononucleosis, and meningitis. This portable device operates independently of electricity or laboratory infrastructure, making it accessible for use in diverse environments. Additionally, Criam's technology is scalable, allowing a single reader to perform multiple tests using specific cartridges and advanced computer vision algorithms. By optimizing blood testing services, Criam aims to provide timely health information and improve clinical decision-making.
Bitome
Seed Round in 2016
Bitome is a Boston-based company specializing in connected medical devices, focusing on noninvasive hydration monitoring technology. Established two years ago, Bitome's first product is designed to monitor hydration status, with significant applications in fields such as dialysis, diabetes management, sports performance, and maternal/fetal health. One of its primary uses is in assessing volume status in patients with congestive heart failure (CHF), a critical but challenging biometric to measure that is closely linked to patient outcomes. By enhancing hydration monitoring, Bitome aims to revolutionize CHF management in a manner similar to how glucose monitoring transformed diabetes care.
Elephant Robotics
Seed Round in 2016
Elephant Robotics, based in the United States, specializes in developing cooperative robots. These robots feature integrated robot arms, voice, and vision systems, making them suitable for tasks such as pick and place, packaging, and testing. The company's products aim to facilitate automation upgrades, ensuring safe work environments, low production costs, and reduced deployment time and risk. Elephant Robotics serves a wide range of industries, including medical, education, agriculture, scientific research, and transportation.
Japet
Seed Round in 2016
Japet Medical Devices is a French biomedical company focused on developing innovative robotic equipment aimed at enhancing treatment quality. The company specializes in wearable robotic exoskeletons that integrate medical and robotic technologies to assist with both occupational and daily health needs. These exoskeletons are designed to restore balance and facilitate free movement, offering pain relief through orthotic support. Japet's commitment to creating user-friendly solutions reflects its belief in the transformative potential of these technologies to improve the quality of life for many individuals.
Sana Health
Pre Seed Round in 2016
Sana Health, Inc. is a digital health company specializing in a bio-therapeutic device aimed at fostering relaxation to alleviate pain and tension. The company has developed a non-addictive mask and headphone system that employs audio-visual stimulation to enhance the balance between the brain's left and right hemispheres, facilitating a deep state of meditation. This innovative device uses coordinated pulses of light and sound to guide users into a restorative state, thereby improving mental well-being and addressing chronic pain and insomnia. In addition to the hardware, Sana Health offers a mobile application available on both the App Store and Google Play, allowing users to access its features conveniently. Founded in 2015 and headquartered in Lafayette, Colorado, with an additional office in Mill Valley, California, Sana Health is involved in pivotal studies concerning its technology's applications for conditions such as fibromyalgia and neuropathic pain, as well as trials focusing on anxiety and PTSD.
nura
Seed Round in 2016
Nura Operations Pty Ltd. is an Australian company founded in 2016 and headquartered in Brunswick. The firm specializes in the development and manufacture of innovative headphones that personalize sound based on users' neural responses to music. Its flagship product, the nuraphone, employs advanced technology to automatically assess individual hearing profiles, adapting audio output to suit each listener's unique auditory characteristics. This personalization is achieved by measuring responses from the outer ear to the brain, ensuring that the headphones deliver an optimal listening experience. Additionally, the nuraphones feature a recognition capability that identifies users upon wearing them, enhancing the personalized experience further.
Feel Therapeutics
Seed Round in 2016
Feel Therapeutics is a digital precision medicine company focused on improving mental health through objective data and passive monitoring. It develops physiological and digital biomarkers alongside therapeutics that aid in the diagnosis, management, and care of mental health conditions. The company's platform includes proprietary medical-grade wearables, such as a wristband equipped with five embedded sensors, which collect biometric data. This data is analyzed using advanced computational methods to create digital biomarkers. By integrating these technologies, Feel Therapeutics aims to provide users with evidence-based insights that enhance their mental well-being and foster the development of lasting positive emotional habits.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.